Journal of investigative dermatology, 2020-06, Vol.140 (6), p.1134-1142
2020
Details
- Autor(en) / Beteiligte
- Titel
- Normalization Cancer Immunotherapy for Melanoma
- Ist Teil von
- Journal of investigative dermatology, 2020-06, Vol.140 (6), p.1134-1142
- Ort / Verlag
- United States: Elsevier Inc
- Erscheinungsjahr
- 2020
- Link zum Volltext
- Quelle
- Alma/SFX Local Collection
- Beschreibungen/Notizen
- Today, we are witnessing a revolution in the treatment of cancer using immunotherapy. In the past decade, work from many laboratories and clinicians has unequivocally demonstrated that the immune system can eradicate established cancers and enhance patient survival. However, immunotherapies have distinct tumor response-to-toxicity profiles owing to distinct mechanisms of action. We have previously termed immunotherapies that activate a general systemic immune response as enhancement cancer immunotherapy and those that target a specific dysfunctional immune response, especially within the tumor microenvironment, as normalization cancer immunotherapy. In this perspective, we provide a framework for normalization cancer immunotherapy in the context of melanoma.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0022-202XeISSN: 1523-1747DOI: 10.1016/j.jid.2020.02.005Titel-ID: cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7247948
- Format
- –
- Schlagworte
- Antineoplastic Agents, Immunological - pharmacology, Antineoplastic Agents, Immunological - therapeutic use, Humans, Immune Checkpoint Inhibitors - pharmacology, Immune Checkpoint Inhibitors - therapeutic use, Immunotherapy - methods, Melanoma - immunology, Melanoma - therapy, Skin Neoplasms - immunology, Skin Neoplasms - therapy, Treatment Outcome, Tumor Escape - drug effects, Tumor Microenvironment - drug effects, Tumor Microenvironment - immunology